When innovation outpaces access: Closing the gap in chronic lymphocytic leukemia care
New targeted therapies have extended survival, improved quality of life, and enabled more personalized treatment decisions based on genetic risk factors, age,...
Industries
Life Sciences
We bring clarity to complex challenges.
For more than 25 years, life science companies, law firms, and regulatory agencies around the globe have turned to CRA’s life sciences consultants when they need clarity and solutions to the industry’s most complex issues. Clients value our deep industry knowledge, rigorous analytic techniques, and decades of hands-on experience spanning thousands of successful engagements.
Engagements
- 01Assessing the market potential of an AI-enabled endoscopy technologyClient issue A leading pharmaceutical R&D company developed a prototype artificial intelligence (AI) model to assess inflammatory bowel disease severity, with...View engagement
- 02Life Sciences Practice supports efforts to harmonize newborn screening across EuropeDespite newborn screening (NBS) being one of the most successful public health interventions of the past century, profound inequalities in access persist...View engagement
- 03Judge cites CRA expert Dr. Josh Sherman's testimony in antitrust trial rulingJudge Bazak-Rapaport’s decision rejected the parties’ narrow relevant market definition and agreed with and cited Dr. Sherman’s testimony from his...View engagement
Contact a Life Sciences expert.
See all Life Sciences expertsUpcoming events
25th Annual Market Access Summit
CRA is a proud sponsor of the event for market access, reimbursement, and government policy experts. Ashley Fraser presents on “MFN – Implications in...
GCR Live: Antitrust in Life Sciences
CRA is a proud sponsor of the event. Josh Sherman is a panelist during the session titled “Global antitrust trends reshaping the life sciences market”...
Recent events
Pharma & Biotech Patent Litigation Summit North America 2026
CRA is a proud sponsor of the conference. Greg Bell speaks during the session titled “Damages in Pharma & Biotech Litigation: What Courts are Accepting...
ISPOR Asia Pacific Summit 2026
CRA is a proud sponsor of the Educational Symposia session titled “The Oncology Combination Therapy Dilemma: Can Today’s HTA Systems Support Tomorrow’s...